Skip to main content
Vor Biopharma Inc. logo

Vor Biopharma Inc. — Investor Relations & Filings

Ticker · VOR ISIN · US9290331084 US Professional, scientific and technical activities
Open in API
Filings indexed 406 across all filing types
Latest filing 2022-04-14 Board/Management Inform…
Country US United States of America
Listing US VOR

About Vor Biopharma Inc.

https://www.vorbio.com/

Vor Biopharma Inc. is a clinical-stage biotechnology company focused on developing treatments for autoimmune diseases. The company is committed to advancing medicines that target the fundamental drivers of autoimmunity, aiming to move beyond symptom control. Its lead candidate, telitacicept, is designed to silence the signals that allow harmful immune cells to survive. The company's objective is to deliver safer, longer-lasting therapies that address the source of autoimmune conditions.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the departure of a Chief Medical Officer due to retirement and related severance arrangements. This fits the category of announcements regarding changes in the company's board of directors or senior management. The document length is 3755 characters, which is relatively short and focused on management change rather than financial results or other report types. Therefore, the appropriate classification is Board/Management Information (MANG).
2022-04-14 English
Regulatory Filings 2022
Regulatory Filings
2022-03-21 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-3. It references a registration statement filing and is a formal correspondence related to securities registration, not a financial report or earnings release. The document length is short (1505 characters) and it is a regulatory communication rather than a report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-03-16 English
Regulatory Filings 2022
Regulatory Filings
2022-03-16 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for sale to the public. It includes a base prospectus and prospectus supplements describing offerings of common stock, preferred stock, debt securities, and warrants. The document is a regulatory filing related to capital raising activities but is not a financial report, earnings release, or management discussion. It is a detailed registration statement for securities issuance under the Securities Act of 1933, which fits the category of Capital/Financing Update filings.
2022-03-14 English
S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Vor Biopharma Inc. on March 14, 2022. Form S-8 is used to register securities to be offered under employee benefit plans such as equity incentive plans and employee stock purchase plans. The document includes details about the registration of additional shares under the 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan. It references incorporation by reference of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, but the document itself is not the 10-K report. It is a registration statement related to capital raising through employee stock plans, which fits the category of Capital/Financing Update filings. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-03-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.